| |
| |
|
| Insider
Information: |
Sheridan William P |
| Relationship: |
Chief Medical Officer |
| City: |
Birmingham |
| State: |
AL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
37,954 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$170,034 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
37,954 |
|
|
| Total
Value |
$170,034 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -20.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biocryst Pharmaceuticals Inc |
BCRX |
Chief Medical Officer |
2022-03-10 |
37,954 |
2009-01-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BCRX |
Biocryst Pharmaceuticals ... |
Chief Medical Officer |
• • – |
2022-03-10 |
4 |
OE |
$3.22 |
$477,532 |
D/D |
148,302 |
199,093 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Chief Medical Officer |
• • – |
2022-03-10 |
4 |
S |
$16.87 |
$2,719,493 |
D/D |
(161,139) |
37,954 |
0 |
% |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Chief Medical Officer |
• • – |
2021-12-14 |
4 |
A |
$0.00 |
$0 |
D/D |
35,000 |
50,791 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Chief Medical Officer |
• • – |
2021-05-28 |
4 |
AS |
$15.02 |
$1,379,046 |
D/D |
(91,814) |
14,475 |
0 |
% |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Chief Medical Officer |
• • – |
2021-05-28 |
4 |
OE |
$4.73 |
$493,826 |
D/D |
91,814 |
106,289 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Chief Medical Officer |
• • – |
2021-05-27 |
4 |
AS |
$15.00 |
$1,076,385 |
D/D |
(71,759) |
14,475 |
0 |
% |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Chief Medical Officer |
• • – |
2021-05-27 |
4 |
OE |
$4.73 |
$378,114 |
D/D |
71,759 |
86,234 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - CMO |
• • – |
2021-02-22 |
4 |
OE |
$4.15 |
$171,188 |
D/D |
41,250 |
52,725 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - CMO |
• • – |
2021-02-22 |
4 |
AS |
$11.57 |
$477,263 |
D/D |
(41,250) |
11,475 |
0 |
% |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - CMO |
• • – |
2019-01-01 |
4 |
D |
$8.07 |
$8,772 |
D/D |
(1,087) |
1,638 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - CMO |
• • – |
2018-12-18 |
4 |
S |
$7.58 |
$155,299 |
D/D |
(20,488) |
2,725 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - CMO |
• • – |
2018-08-09 |
4 |
AS |
$7.03 |
$439,375 |
D/D |
(62,500) |
23,213 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - CMO |
• • – |
2018-08-09 |
4 |
OE |
$1.42 |
$88,750 |
D/D |
62,500 |
85,713 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - CMO |
• • – |
2018-06-01 |
4 |
OE |
$2.58 |
$108,649 |
D/D |
42,112 |
63,170 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - CMO |
• • – |
2018-06-01 |
4 |
AS |
$6.30 |
$265,306 |
D/D |
(42,112) |
21,058 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - CMO |
• • – |
2018-01-20 |
4 |
D |
$5.59 |
$25,871 |
D/D |
(4,628) |
18,058 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - CMO |
• • – |
2018-01-01 |
4 |
D |
$4.91 |
$5,740 |
D/D |
(1,169) |
22,686 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - CMO |
• • – |
2017-11-13 |
4 |
AS |
$4.72 |
$303,543 |
D/D |
(64,310) |
23,855 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - CMO |
• • – |
2017-01-20 |
4 |
D |
$5.95 |
$34,278 |
D/D |
(5,761) |
82,916 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - CMO |
• • – |
2017-01-01 |
4 |
D |
$6.33 |
$13,173 |
D/D |
(2,081) |
88,677 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - CMO |
• • – |
2016-03-01 |
4 |
D |
$2.13 |
$1,702 |
D/D |
(799) |
90,052 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - CMO |
• • – |
2016-01-20 |
4 |
D |
$7.55 |
$40,460 |
D/D |
(5,359) |
88,967 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - CMO |
• • – |
2016-01-01 |
4 |
D |
$10.32 |
$21,476 |
D/D |
(2,081) |
94,326 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - CMO |
• • – |
2015-06-19 |
4 |
AS |
$15.05 |
$1,059,354 |
D/D |
(70,389) |
95,123 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - CMO |
• • – |
2015-06-19 |
4 |
OE |
$1.20 |
$84,467 |
D/D |
70,389 |
165,512 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
